The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
Dr Reddy has made remarkable contributions towards advancing cancer care through clinical excellence, pioneering research, academic mentorship, and compassionate healing
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
Eylea 2mg (intravitreal aflibercept injection) is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina
It promises fewer injections for vision loss patients
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
Subscribe To Our Newsletter & Stay Updated
